Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 NexPoint Acquires Mfg. Property for Kindeva Drug Delivery | Contract Pharma

What are you searching for?

Sign in
Breaking News

NexPoint Acquires Mfg. Property for Kindeva Drug Delivery

R&D facility has clinical manufacturing and lab space offering a range of capabilities to support drug delivery solutions.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

NexPoint, an investment firm, launched NexPoint Life Sciences III DST, a Delaware Statutory Trust, which acquired a life sciences industrial manufacturing property in Woodbury, MN. The DST expects to raise approximately $31 million through the offering.

The 138,000-square-foot property is the global headquarters for Kindeva Drug Delivery, a contract development and manufacturing organization (CDMO) that develops and manufactures products across a range of complex drug-delivery formats. The property is a research, formulation, and development facility for Kindeva with clinical manufacturing space, development lab space, offering a range of capabilities to support drug delivery solutions.

“Within life sciences, we see long-term value in facilities that support the growth of high demand biomanufacturing,” said Matt McGraner, NexPoint Real Estate Advisors’ chief investment officer. “CDMOs play a major role in that, helping life sciences companies reduce time to market, increase capacity, and successfully navigate the path to commercialization, making opportunities to invest in CDMO-operated facilities especially compelling.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics